REDWOOD CITY, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective February 1, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 22,500 shares of the common stock of the Company to three newly hired employees with a per share exercise price of $8.65, the closing trading price on the grant date.
The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.
Coherus BioSciences Contact Information:
IR Contact
Marek Ciszewski
Coherus BioSciences, Inc.
IR@coherus.com
- Block, Inc.Shareholder News: Johnson Fistel Urges Investors with Losses to Reach Out Regarding Class Action Investigation - March 23, 2023
- New to The Street Signs SMX (Security Matters) Public Limited Company to 12 Month TV Series, Contract Includes Iconic Billboard Ads and Commercial Support - March 23, 2023
- TWO MEN AND A TRUCK Has Donated More Than $425,000 to Convoy of Hope - March 23, 2023
